Global Medical REIT Inc
(NYSE:GMRE)
The dividend Ex-Date was 3 days ago
$9.01
-0.03[-0.33%]
Last update: 3:59PM (Delayed 15-Minutes)
Get Real Time Here
$9.00
-0.0100[-0.11%]
Open9.050Close9.000
Vol / Avg.216.320K / 326.712KMkt Cap590.740M
Day Range9.000 - 9.17052 Wk Range7.040 - 11.790

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%

Global Medical REIT Stock (NYSE:GMRE), Key Statistics

Global Medical REIT Stock (NYSE: GMRE) analysis, key statistics.

Valuation Measures
Enterprise Value
1.3B
Trailing P/E
28.25
Forward P/E
- -
PE Ratio (TTM)
64.99
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.11
Price / Book (mrq)
1.09
Price / EBITDA
4.93
Enterprise Value / EBITDA (TTM)
10.8
Earnings Yield
3.54%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
8.31
Tangible Book value per share
6.41
Total Liabilities (Quarterly)
679.4M
Total Assets
1.3B
Total Liabilities
679.4M
Profitability
Net income Growth
2.6
Gross Margin
80.11%
Net Margin
32.55%
EBIT Margin
62.35%
EBITDA Margin
103.82%
Operating Margin
27.06%